D. M. GREEN, M.D., F.A.C.P.
This content is PDF only. Please click on the PDF icon to access.
Experimental hypertension has made three useful contributions to clinical medicine: insight into the possible pathogenesis of essential hypertension, explanations for our therapeutic failures, and opportunities for the development and perfection of new methods of treatment. The basis for these relationships is perhaps best illustrated by a comparison of human hypertension with the principal varieties of the experimental disease.
Although the blood pressure can be increased in animals by a great number of methods, consistent and sustained elevations have been associated with three major types of experimental hypertension: (a) neurogenic; (b) renal and (c) desoxycorticosterone acetate (DCA)-induced.
GREEN DM. EXPERIMENTAL HYPERTENSION*. Ann Intern Med. 1953;39:333–344. doi: https://doi.org/10.7326/0003-4819-39-2-333
Download citation file:
Published: Ann Intern Med. 1953;39(2):333-344.
Cardiology, Coronary Risk Factors, Hypertension, Nephrology.
Results provided by:
Copyright © 2020 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use